News

Creative disruption of an existing model can be the path forward to a new technology, such as telehealth, a market that has grown rapidly since 2012, and is expected to continue to do so over the next several years.

Artificial intelligence has the potential to have a significant impact on ophthalmology in the coming years.

Ophthalmology Times seeks nominations of residents to participate in our 2019 Resident Writers Award program. The nominations are due by May 3, 2019-learn how. 

Eye drops, drug-delivery system innovations aim to improve outcomes, adherence

Differing signaling pathways could lead to different types of cataracts in children.

Deep Phenotyping is shedding new light on congenital corneal opacities, and with the initial diagnoses, physicians should also delve deeper to avoid overlooking the causes of some ocular anomalies.

Peter J. McDonnell, MD, discusses a cottage industry that sells wall plaques touting a physician's "accomplishments." Is it a legitimate offer or are they just after your money?

If you find yourself waffling back and forth on private equity, Ruth D. Williams, MD, has some guidance tips to make the decision easier. 

Janey L. Wiggs, MD, PhD, shares the key points from her presentation.

Thermal pulsation therapy has potential to improve gland structure in most patients.

Ellie Chabi, MD, Therapeutic Area Head for Glaucoma & Neuroprotection and Lead for Artificial Intelligence Programs within Global Biomedical Science for Santen, provides an update on its glaucoma pipeline.

Joel S. Schuman, MD, FACS, shares what's in store for regenerative ophthalmology at the annual Glaucoma 360 2019 meeting. 

Robert L. Stamper, MD, discusses the current state of OCT angiography, and what remains on the horizon for glaucoma care.

Yvonne Ou, MD, discusses Glaucoma 360's first-ever "Shark Tank" competition at the 2019 meeting.

Drs. Graves and Iwach, co-founders of the Glaucoma 360 meeting, discuss the biggest advances in innovation and research at the 23rd annual meeting at the Palace Hotel in San Francisco on Feb. 2, 2019.

Shan C. Lin, MD, provides the key takeaways from his presentation at the annual Glaucoma 360 meeting.

"If you think this has a happy ending, you haven't been paying attention." - Ramsay Bolton.

The 2019 annual meetings of the American Society of Cataract and Refractive Surgery and the American Society of Ophthalmic Administrators will be held May 3 to 7 in San Diego.

L. Jay Katz, MD, delivered the Shaffer‐Hetherington‐Hoskins Lecture, "Screening for Glaucoma: New Strategies" at the 23rd annual Glaucoma 360 meeting at the Palace Hotel in San Francisco on Feb. 2, 2019. Here, he shares his take-home message for clinicians.

If you have a product idea, no matter how simple or elaborate, just go for it! You never know where it will lead you, says Joshua Mali, MD. 

For the first time ever, the Association for Research in Vision and Ophthalmology (ARVO) is taking its annual meeting outside the United States, heading north of the border to Vancouver, British Columbia. 

“THE BEEEEEEEES!”-Nicolas Cage 

Analytics may help EyeMDs to provide appropriate access, quality, cost of care

New loteprednol gel reduces drop burden for treatment of postoperative inflammation, pain

Disparities exist in delivery of needed vision care for at-risk children, study finds

Study finds similar results for patients who received hydrophobic, hydrophilic acrylic lenses

Robin R. Vann, MD, and Douglas D. Koch, MD, discuss the nuances of the procedure